Detalhe da pesquisa
1.
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.
N Engl J Med
; 386(21): 1998-2010, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613022
2.
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.
Ann Hematol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780802
3.
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
Blood
; 138(9): 749-757, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33876223
4.
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.
Blood
; 138(15): 1331-1344, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971010
5.
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Ann Hematol
; 102(11): 3015-3023, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535147
6.
Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes.
Inflamm Res
; 72(8): 1695-1707, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507570
7.
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Br J Haematol
; 198(1): 103-113, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277855
8.
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome.
Platelets
; 32(3): 378-382, 2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268817
9.
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Am J Hematol
; 90(5): E80-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653205
10.
Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec.
Br J Haematol
; 186(4): 639-640, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044416
11.
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
Br J Haematol
; 186(4): e100-e103, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016714
12.
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
Br J Haematol
; 185(5): 954-957, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407614
13.
Why methylation is not a marker predictive of response to hypomethylating agents.
Haematologica
; 99(4): 613-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24688109
14.
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions.
Exp Hematol
; 129: 104118, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741607
15.
Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.
Am J Hematol
; 93(5): E120-E123, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417611
16.
Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution.
Mediterr J Hematol Infect Dis
; 15(1): e2023064, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028397
17.
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
Blood Adv
; 7(17): 5122-5131, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327116
18.
De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences.
Mediterr J Hematol Infect Dis
; 14(1): e2022030, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615324
19.
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19.
Mediterr J Hematol Infect Dis
; 14(1): e2022041, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615323
20.
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.
Front Oncol
; 12: 871590, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35494081